This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Greetings and welcome to the Theragenics’ Third Quarter 2011 Earnings Conference Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. (Operator Instructions)
It is now my pleasure to introduce your host Christine Jacobs, Chairman and CEO of Theragenics. Thank you, Ms. Jacobs. You may begin.
Thank you, Melissa. Good morning all and welcome to Theragenics’ third quarter 2011 conference call. Thank you for joining us this morning. In a few minutes I’ll provide some comments on the quarter and outlook for the remainder of the year, but first Frank Tarallo, our Chief Financial Officer will provide a review of the financial results, Frank.
Thank you, Chris. This morning we released our consolidated financial results for the third quarter of 2011. If you did not receive this news release or if you would like to be added to either our fax or email distribution list, please contact Investor Relations at 800-998-8479, or 770-271-0233.
Before I begin my review, please be aware that some comments made during this conference call may contain forward-looking statements involving risks and uncertainties regarding our operations and future results. Please see our press release issued today and our filings with the Securities and Exchange Commission, including without limitation, the company’s Form 10-K and Forms 10-Q, which identifies specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.